Cresco Labs Inc. (CSE:CL)
Canada
· Delayed Price · Currency is CAD 1.030
-0.080 (-7.21%)
Mar 31, 2025, 1:23 PM EST
Cresco Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 715.76 | 756.06 | 824.93 | 805.68 | 463.08 | Upgrade
|
| Revenue Growth (YoY) | -5.33% | -8.35% | 2.39% | 73.98% | 272.87% | Upgrade
|
| Cost of Revenue | 359.89 | 408.52 | 430.2 | 375.9 | 252.63 | Upgrade
|
| Gross Profit | 355.87 | 347.54 | 394.73 | 429.79 | 210.45 | Upgrade
|
| Selling, General & Admin | 220.75 | 247.08 | 309.86 | 276 | 198.65 | Upgrade
|
| Other Operating Expenses | - | - | - | 16 | 13.17 | Upgrade
|
| Operating Expenses | 243.92 | 282.01 | 330.5 | 313.6 | 228.95 | Upgrade
|
| Operating Income | 111.95 | 65.53 | 64.23 | 116.18 | -18.5 | Upgrade
|
| Interest Expense | -58.9 | -63.62 | -58.52 | -52.15 | -32.64 | Upgrade
|
| Interest & Investment Income | 2.92 | 2.8 | 0.68 | 0.94 | 1.41 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -1.2 | -1.18 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.04 | -0.3 | 0.93 | -1.23 | -1.42 | Upgrade
|
| Other Non Operating Income (Expenses) | -65.36 | -1.91 | -0.7 | 26.91 | -5.61 | Upgrade
|
| EBT Excluding Unusual Items | -8.35 | 2.5 | 6.62 | 89.46 | -57.93 | Upgrade
|
| Merger & Restructuring Charges | 0.13 | - | -5.47 | -27.64 | -3.75 | Upgrade
|
| Impairment of Goodwill | - | -50.86 | -117.02 | -215.55 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | -0.41 | -4.59 | 1.29 | -0.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.68 | 0.76 | 12.31 | -1.11 | -0.13 | Upgrade
|
| Asset Writedown | -2.32 | -100.16 | -23.63 | -90.34 | -1.22 | Upgrade
|
| Legal Settlements | 0.27 | - | - | - | - | Upgrade
|
| Other Unusual Items | -1 | 1.26 | 4.88 | -12.83 | -0.98 | Upgrade
|
| Pretax Income | -10.62 | -146.9 | -126.91 | -256.73 | -64.17 | Upgrade
|
| Income Tax Expense | 49.87 | 32.95 | 88.94 | 40.11 | 28.6 | Upgrade
|
| Earnings From Continuing Operations | -60.49 | -179.85 | -215.84 | -296.83 | -92.77 | Upgrade
|
| Minority Interest in Earnings | -13.95 | 4.33 | 3.8 | -22.76 | -9.39 | Upgrade
|
| Net Income | -74.44 | -175.52 | -212.05 | -319.6 | -102.16 | Upgrade
|
| Net Income to Common | -74.44 | -175.52 | -212.05 | -319.6 | -102.16 | Upgrade
|
| Shares Outstanding (Basic) | 345 | 324 | 298 | 262 | 210 | Upgrade
|
| Shares Outstanding (Diluted) | 345 | 324 | 298 | 262 | 210 | Upgrade
|
| Shares Change (YoY) | 6.69% | 8.61% | 13.66% | 24.64% | 77.88% | Upgrade
|
| EPS (Basic) | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 | Upgrade
|
| Free Cash Flow | 112.99 | 3.18 | -64.29 | -79.39 | -95 | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.01 | -0.22 | -0.30 | -0.45 | Upgrade
|
| Gross Margin | 49.72% | 45.97% | 47.85% | 53.34% | 45.45% | Upgrade
|
| Operating Margin | 15.64% | 8.67% | 7.79% | 14.42% | -3.99% | Upgrade
|
| Profit Margin | -10.40% | -23.21% | -25.70% | -39.67% | -22.06% | Upgrade
|
| Free Cash Flow Margin | 15.79% | 0.42% | -7.79% | -9.85% | -20.52% | Upgrade
|
| EBITDA | 171.05 | 128.04 | 116.16 | 154.82 | 13.29 | Upgrade
|
| EBITDA Margin | 23.90% | 16.93% | 14.08% | 19.22% | 2.87% | Upgrade
|
| D&A For EBITDA | 59.1 | 62.51 | 51.93 | 38.64 | 31.79 | Upgrade
|
| EBIT | 111.95 | 65.53 | 64.23 | 116.18 | -18.5 | Upgrade
|
| EBIT Margin | 15.64% | 8.67% | 7.79% | 14.42% | -3.99% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.